FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children ...

The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma , to help ...

The global Topical Drug Delivery Market, valued at US$247.3 billion in 2024 stood at US$268.4 billion in 2025 and is ...

One of the investment banks whose price target for Teva's stock is among the highest is Oppenheimer with a price target of ...

The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and is projected to ...

Teva's transformation boosts profit growth and specialty drugs, offering an undervalued opportunity. Click here to read my ...

The global Cancer Pain Market is valued at USD 6983.5 Million in 2024 and is projected to reach a value of USD 12031.1 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 5.1% between 2025 and ...

Generic drugs had a "stable" performance in the second quarter, with global revenue down about 2% in local currency.

Teva’s chief drug Austedo—approved in Huntington’s disease and tardive dyskinesia—grew sales 19% to $498 million for the ...

Teva Pharmaceutical Industries reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26 ...

Jewish leadership starts with emunah—faithfulness and integrity. Leaders like Moses and the tribal heads are expected to ...